These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34981659)

  • 1. The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma.
    Zhang X; Li N; Zhu Y; Wen W
    Cancer Med; 2022 Feb; 11(4):931-943. PubMed ID: 34981659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.
    Yin Z; Jiang K; Li R; Dong C; Wang L
    Mol Cancer; 2018 Dec; 17(1):178. PubMed ID: 30593276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma cell line-microenvironment induced cancer-associated phenotype, genotype and functionality in mesenchymal stem cells.
    Salah RA; Nasr MA; El-Derby AM; Abd Elkodous M; Mohamed RH; El-Ekiaby N; Osama A; Elshenawy SE; Hamad MHM; Magdeldin S; Gabr MM; Abdelaziz AI; El-Badri NS
    Life Sci; 2022 Jan; 288():120168. PubMed ID: 34826437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversibility of hAT-MSCs phenotypic and metabolic changes after exposure to and withdrawal from HCC-conditioned medium through regulation of the ROS/MAPK/HIF-1α signaling pathway.
    Wang C; Hu J; Chen Z; Wang Y; Lu S; Zhang Y; Li Y; Xiang Y; Ji Y; Zeng C; Ding Y; Wang W
    Stem Cell Res Ther; 2020 Nov; 11(1):506. PubMed ID: 33246501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
    Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
    J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma.
    Hernanda PY; Pedroza-Gonzalez A; van der Laan LJ; Bröker ME; Hoogduijn MJ; Ijzermans JN; Bruno MJ; Janssen HL; Peppelenbosch MP; Pan Q
    Carcinogenesis; 2013 Oct; 34(10):2330-40. PubMed ID: 23740837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.
    Bayo J; Fiore E; Aquino JB; Malvicini M; Rizzo M; Peixoto E; Andriani O; Alaniz L; Piccioni F; Bolontrade M; Podhajcer O; Garcia MG; Mazzolini G
    PLoS One; 2014; 9(4):e95171. PubMed ID: 24736611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
    Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
    Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo.
    Alshareeda AT; Alsowayan B; Almubarak A; Alghuwainem A; Alshawakir Y; Alahmed M
    J Vis Exp; 2018 Sep; (139):. PubMed ID: 30272642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
    Wu Q; Zhou L; Lv D; Zhu X; Tang H
    J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
    Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
    Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.
    Frisbie L; Buckanovich RJ; Coffman L
    Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells.
    Pelagalli A; Nardelli A; Fontanella R; Zannetti A
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stem Cells in the Tumor Microenvironment.
    Atiya H; Frisbie L; Pressimone C; Coffman L
    Adv Exp Med Biol; 2020; 1234():31-42. PubMed ID: 32040853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma.
    Chen J; Ji T; Wu D; Jiang S; Zhao J; Lin H; Cai X
    Cell Death Dis; 2019 May; 10(6):425. PubMed ID: 31142737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells.
    Huang H; Tsui YM; Ng IO
    Cell Mol Gastroenterol Hepatol; 2023; 15(5):1105-1116. PubMed ID: 36736664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
    Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
    Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma.
    Seyhoun I; Hajighasemlou S; Muhammadnejad S; Ai J; Nikbakht M; Alizadeh AA; Hosseinzadeh F; Mirmoghtadaei M; Seyhoun SM; Verdi J
    J Cell Physiol; 2019 Jun; 234(6):9495-9503. PubMed ID: 30362607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.